Intuitive Surgical, Inc. Income Tax Expense
Intuitive Surgical, Inc. (ISRG) reported Income Tax Expense of $231.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-21
- Intuitive Surgical, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $231.40M, a 37.82% increase year-over-year.
- Intuitive Surgical, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $114.40M.
- Intuitive Surgical, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $156.10M, a 28.16% increase year-over-year.
- Intuitive Surgical, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $146.00M, a 45.42% increase year-over-year.
- Intuitive Surgical, Inc. income tax expense (benefit) for fiscal 2025 was $434.80M, a 29.29% increase from fiscal 2024.
- Intuitive Surgical, Inc. income tax expense (benefit) for fiscal 2024 was $336.30M, a 137.50% increase from fiscal 2023.
- Intuitive Surgical, Inc. income tax expense (benefit) for fiscal 2023 was $141.60M, a 46.04% decline from fiscal 2022.
- Intuitive Surgical, Inc. income tax expense (benefit) for fiscal 2022 was $262.40M, a 61.78% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $231.40M 10-Q · filed 2026-07-21 | $345.80M 10-Q · filed 2026-07-21 | $501.90M derived: sum of 3 quarters · filed 2026-07-21 | $647.90M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2026-03-31 | $114.40M 10-Q · filed 2026-04-22 | $270.50M derived: sum of 2 quarters · filed 2026-04-22 | $416.50M derived: sum of 3 quarters · filed 2026-04-22 | $584.40M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-12-31 | $156.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $302.10M derived: sum of 2 quarters · filed 2026-02-03 | $470.00M derived: sum of 3 quarters · filed 2026-07-21 | $434.80M 10-K · filed 2026-02-03 | ||||
| 2025-09-30 | $146.00M 10-Q · filed 2025-10-22 | $313.90M derived: sum of 2 quarters · filed 2026-07-21 | $278.70M 10-Q · filed 2025-10-22 | $400.50M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-06-30 | $167.90M 10-Q · filed 2026-07-21 | $132.70M 10-Q · filed 2026-07-21 | $254.50M derived: sum of 3 quarters · filed 2026-07-21 | $354.90M derived: sum of 4 quarters · filed 2026-07-21 | ||||
| 2025-03-31 | -$35.20M 10-Q · filed 2026-04-22 | $86.60M derived: sum of 2 quarters · filed 2026-04-22 | $187.00M derived: sum of 3 quarters · filed 2026-04-22 | $310.00M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-31 | $121.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $222.20M derived: sum of 2 quarters · filed 2026-02-03 | $345.20M derived: sum of 3 quarters · filed 2026-02-03 | $336.30M 10-K · filed 2026-02-03 | ||||
| 2024-09-30 | $100.40M 10-Q · filed 2025-10-22 | $223.40M derived: sum of 2 quarters · filed 2025-10-22 | $214.50M 10-Q · filed 2025-10-22 | $119.70M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-06-30 | $123.00M 10-Q · filed 2025-07-23 | $114.10M 10-Q · filed 2025-07-23 | $19.30M derived: sum of 3 quarters · filed 2026-02-03 | $121.50M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2024-03-31 | -$8.90M 10-Q · filed 2025-04-23 | -$103.70M derived: sum of 2 quarters · filed 2026-02-03 | -$1.50M derived: sum of 3 quarters · filed 2026-02-03 | $71.70M derived: sum of 4 quarters · filed 2026-02-03 | ||||
| 2023-12-31 | -$94.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $7.40M derived: sum of 2 quarters · filed 2026-02-03 | $80.60M derived: sum of 3 quarters · filed 2026-02-03 | $141.60M 10-K · filed 2026-02-03 | ||||
| 2023-09-30 | $102.20M 10-Q · filed 2024-10-18 | $175.40M derived: sum of 2 quarters · filed 2024-10-18 | $236.40M 10-Q · filed 2024-10-18 | $294.40M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-06-30 | $73.20M 10-Q · filed 2024-07-19 | $134.20M 10-Q · filed 2024-07-19 | $192.20M derived: sum of 3 quarters · filed 2025-01-31 | $270.30M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2023-03-31 | $61.00M 10-Q · filed 2024-04-19 | $119.00M derived: sum of 2 quarters · filed 2025-01-31 | $197.10M derived: sum of 3 quarters · filed 2025-01-31 | $290.40M derived: sum of 4 quarters · filed 2025-01-31 | ||||
| 2022-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $136.10M derived: sum of 2 quarters · filed 2025-01-31 | $229.40M derived: sum of 3 quarters · filed 2025-01-31 | $262.40M 10-K · filed 2025-01-31 | ||||
| 2022-09-30 | $78.10M 10-Q · filed 2023-10-20 | $171.40M derived: sum of 2 quarters · filed 2023-10-20 | $204.40M 10-Q · filed 2023-10-20 | $275.90M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-06-30 | $93.30M 10-Q · filed 2023-07-24 | $126.30M 10-Q · filed 2023-07-24 | $197.80M derived: sum of 3 quarters · filed 2024-01-31 | $271.70M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2022-03-31 | $33.00M 10-Q · filed 2023-04-20 | $104.50M derived: sum of 2 quarters · filed 2024-01-31 | $178.40M derived: sum of 3 quarters · filed 2024-01-31 | $181.60M derived: sum of 4 quarters · filed 2024-01-31 | ||||
| 2021-12-31 | $71.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $145.40M derived: sum of 2 quarters · filed 2024-01-31 | $148.60M derived: sum of 3 quarters · filed 2024-01-31 | $162.20M 10-K · filed 2024-01-31 | ||||
| 2021-09-30 | $73.90M 10-Q · filed 2022-10-21 | $77.10M derived: sum of 2 quarters · filed 2022-10-21 | $90.70M 10-Q · filed 2022-10-21 | $163.60M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-06-30 | $3.20M 10-Q · filed 2022-07-22 | $16.80M 10-Q · filed 2022-07-22 | $89.70M derived: sum of 3 quarters · filed 2023-02-10 | $128.10M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2021-03-31 | $13.60M 10-Q · filed 2022-04-22 | $86.50M derived: sum of 2 quarters · filed 2023-02-10 | $124.90M derived: sum of 3 quarters · filed 2023-02-10 | $161.90M derived: sum of 4 quarters · filed 2023-02-10 | ||||
| 2020-12-31 | $72.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $111.30M derived: sum of 2 quarters · filed 2023-02-10 | $148.30M derived: sum of 3 quarters · filed 2023-02-10 | $140.20M 10-K · filed 2023-02-10 | ||||
| 2020-09-30 | $38.40M 10-Q · filed 2021-10-20 | $75.40M derived: sum of 2 quarters · filed 2021-10-20 | $67.30M 10-Q · filed 2021-10-20 | $136.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $37.00M 10-Q · filed 2021-07-21 | $28.90M 10-Q · filed 2021-07-21 | $97.90M derived: sum of 3 quarters · filed 2022-02-03 | $98.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$8.10M 10-Q · filed 2021-04-21 | $60.90M derived: sum of 2 quarters · filed 2022-02-03 | $61.20M derived: sum of 3 quarters · filed 2022-02-03 | $136.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $69.30M derived: sum of 2 quarters · filed 2022-02-03 | $144.70M derived: sum of 3 quarters · filed 2022-02-03 | $120.40M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $300.00K 10-Q · filed 2020-10-19 | $75.70M derived: sum of 2 quarters · filed 2020-10-19 | $51.40M 10-Q · filed 2020-10-19 | $118.90M derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-06-30 | $75.40M 10-Q · filed 2020-07-23 | $51.10M 10-Q · filed 2020-07-23 | $118.60M derived: sum of 3 quarters · filed 2021-02-10 | $162.00M derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-03-31 | -$24.30M 10-Q · filed 2020-04-17 | $43.20M derived: sum of 2 quarters · filed 2021-02-10 | $86.60M derived: sum of 3 quarters · filed 2021-02-10 | $127.60M derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2018-12-31 | $67.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $110.90M derived: sum of 2 quarters · filed 2021-02-10 | $151.90M derived: sum of 3 quarters · filed 2021-02-10 | $154.50M 10-K · filed 2021-02-10 | ||||
| 2018-09-30 | $43.40M 10-Q · filed 2019-10-18 | $84.40M derived: sum of 2 quarters · filed 2019-10-18 | $87.00M 10-Q · filed 2019-10-18 | $459.80M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-06-30 | $41.00M 10-Q · filed 2019-07-22 | $43.60M 10-Q · filed 2019-07-22 | $416.40M derived: sum of 3 quarters · filed 2020-02-07 | $409.20M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2018-03-31 | $2.60M 10-Q · filed 2019-04-19 | $375.40M derived: sum of 2 quarters · filed 2020-02-07 | $368.20M derived: sum of 3 quarters · filed 2020-02-07 | $415.20M derived: sum of 4 quarters · filed 2020-02-07 | ||||
| 2017-12-31 | $372.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $365.60M derived: sum of 2 quarters · filed 2020-02-07 | $412.60M derived: sum of 3 quarters · filed 2020-02-07 | $433.90M 10-K · filed 2020-02-07 | $436.50M 10-K · filed 2018-02-02 | |||
| 2017-09-30 | -$7.20M 10-Q · filed 2018-10-22 | -$8.10M 10-Q · filed 2017-10-20 | $39.80M derived: sum of 2 quarters · filed 2018-10-22 | $61.10M 10-Q · filed 2018-10-22 | $58.40M 10-Q · filed 2017-10-20 | $135.30M derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-06-30 | $47.00M 10-Q · filed 2018-07-20 | $46.10M 10-Q · filed 2017-07-21 | $68.30M 10-Q · filed 2018-07-20 | $66.50M 10-Q · filed 2017-07-21 | $142.50M derived: sum of 3 quarters · filed 2019-02-04 | $198.30M derived: sum of 4 quarters · filed 2019-02-04 | ||
| 2017-03-31 | $21.30M 10-Q · filed 2018-04-18 | $20.40M 10-Q · filed 2017-04-19 | $95.50M derived: sum of 2 quarters · filed 2019-02-04 | $151.30M derived: sum of 3 quarters · filed 2019-02-04 | $220.20M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2016-12-31 | $74.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $130.00M derived: sum of 2 quarters · filed 2019-02-04 | $198.90M derived: sum of 3 quarters · filed 2019-02-04 | $247.00M 10-K · filed 2019-02-04 | $244.90M 10-K · filed 2017-02-06 | |||
| 2016-09-30 | $55.80M 10-Q · filed 2017-10-20 | $124.70M derived: sum of 2 quarters · filed 2017-10-20 | $172.80M 10-Q · filed 2017-10-20 | $234.60M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2016-06-30 | $68.90M 10-Q · filed 2017-07-21 | $117.00M 10-Q · filed 2017-07-21 | $178.80M derived: sum of 3 quarters · filed 2018-02-02 | $208.10M derived: sum of 4 quarters · filed 2019-07-22 | ||||
| 2016-03-31 | $48.10M 10-Q · filed 2017-04-19 | $109.90M derived: sum of 2 quarters · filed 2018-02-02 | $139.20M derived: sum of 3 quarters · filed 2019-07-22 | $183.10M derived: sum of 4 quarters · filed 2019-07-22 | ||||
| 2015-12-31 | $61.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $91.10M derived: sum of 2 quarters · filed 2019-07-22 | $135.00M derived: sum of 3 quarters · filed 2019-07-22 | $169.70M 10-K · filed 2018-02-02 | ||||
| 2015-09-30 | $29.30M 10-Q · filed 2019-07-22 | $26.30M 10-Q · filed 2015-10-21 | $73.20M derived: sum of 2 quarters · filed 2019-07-22 | $107.90M 10-Q · filed 2016-10-19 | $148.90M derived: sum of 4 quarters · filed 2019-07-22 | |||
| 2015-06-30 | $43.90M 10-Q · filed 2016-07-20 | $81.60M 10-Q · filed 2016-07-20 | $119.60M derived: sum of 3 quarters · filed 2017-02-06 | $157.00M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-03-31 | $37.70M 10-Q · filed 2016-04-19 | $75.70M derived: sum of 2 quarters · filed 2017-02-06 | $113.10M derived: sum of 3 quarters · filed 2017-02-06 | $151.70M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2014-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $75.40M derived: sum of 2 quarters · filed 2017-02-06 | $114.00M derived: sum of 3 quarters · filed 2017-02-06 | $130.20M 10-K · filed 2017-02-06 | ||||
| 2014-09-30 | $37.40M 10-Q · filed 2015-10-21 | $76.00M derived: sum of 2 quarters · filed 2015-10-21 | $92.20M 10-Q · filed 2015-10-21 | $140.50M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-06-30 | $38.60M 10-Q · filed 2015-07-22 | $54.80M 10-Q · filed 2015-07-22 | $103.10M derived: sum of 3 quarters · filed 2016-02-02 | $124.40M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-03-31 | $16.20M 10-Q · filed 2015-04-22 | $64.50M derived: sum of 2 quarters · filed 2016-02-02 | $85.80M derived: sum of 3 quarters · filed 2016-02-02 | $149.50M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2013-12-31 | $48.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $69.60M derived: sum of 2 quarters · filed 2016-02-02 | $133.30M derived: sum of 3 quarters · filed 2016-02-02 | $199.90M 10-K · filed 2016-02-02 | ||||
| 2013-09-30 | $21.30M 10-Q · filed 2014-10-23 | $85.00M derived: sum of 2 quarters · filed 2014-10-23 | $151.60M 10-Q · filed 2014-10-23 | $228.50M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-06-30 | $63.70M 10-Q · filed 2014-07-24 | $130.30M 10-Q · filed 2014-07-24 | $207.20M derived: sum of 3 quarters · filed 2015-02-06 | $239.60M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-03-31 | $66.60M 10-Q · filed 2014-04-25 | $143.50M derived: sum of 2 quarters · filed 2015-02-06 | $175.90M derived: sum of 3 quarters · filed 2015-02-06 | $250.30M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2012-12-31 | $76.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $109.30M derived: sum of 2 quarters · filed 2015-02-06 | $183.70M derived: sum of 3 quarters · filed 2015-02-06 | $237.30M 10-K · filed 2015-02-06 | ||||
| 2012-09-30 | $32.40M 10-Q · filed 2013-10-18 | $106.80M derived: sum of 2 quarters · filed 2013-10-18 | $160.40M 10-Q · filed 2013-10-18 | $212.30M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-06-30 | $74.40M 10-Q · filed 2013-07-22 | $128.00M 10-Q · filed 2013-07-22 | $179.90M derived: sum of 3 quarters · filed 2014-02-03 | $238.30M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-03-31 | $53.60M 10-Q · filed 2013-04-19 | $105.50M derived: sum of 2 quarters · filed 2014-02-03 | $163.90M derived: sum of 3 quarters · filed 2014-02-03 | $218.70M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2011-12-31 | $51.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $110.30M derived: sum of 2 quarters · filed 2014-02-03 | $165.10M derived: sum of 3 quarters · filed 2014-02-03 | $214.60M 10-K · filed 2014-02-03 | ||||
| 2011-09-30 | $58.40M 10-Q · filed 2012-10-18 | $113.20M derived: sum of 2 quarters · filed 2012-10-18 | $162.70M 10-Q · filed 2012-10-18 | $198.70M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-06-30 | $54.80M 10-Q · filed 2012-07-23 | $104.30M 10-Q · filed 2012-07-23 | $140.30M derived: sum of 3 quarters · filed 2013-02-04 | $190.80M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-03-31 | $49.50M 10-Q · filed 2012-04-19 | $85.50M derived: sum of 2 quarters · filed 2013-02-04 | $136.00M derived: sum of 3 quarters · filed 2013-02-04 | $191.50M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2010-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $86.50M derived: sum of 2 quarters · filed 2013-02-04 | $142.00M derived: sum of 3 quarters · filed 2013-02-04 | $190.50M 10-K · filed 2013-02-04 | ||||
| 2010-09-30 | $50.50M 10-Q · filed 2011-10-19 | $106.00M derived: sum of 2 quarters · filed 2011-10-19 | $154.50M 10-Q · filed 2011-10-19 | $209.50M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-06-30 | $55.50M 10-Q · filed 2011-07-20 | $104.00M 10-Q · filed 2011-07-20 | $159.00M derived: sum of 3 quarters · filed 2012-02-06 | $203.30M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-03-31 | $48.50M 10-Q · filed 2011-04-20 | $103.50M derived: sum of 2 quarters · filed 2012-02-06 | $147.80M derived: sum of 3 quarters · filed 2012-02-06 | $190.10M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2009-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $99.30M derived: sum of 2 quarters · filed 2012-02-06 | $141.60M derived: sum of 3 quarters · filed 2012-02-06 | $163.50M 10-K · filed 2012-02-06 | $163.50M 10-K · filed 2010-01-29 | |||
| 2009-09-30 | $44.30M 10-Q · filed 2010-10-20 | $44.33M 10-Q · filed 2009-10-21 | $86.60M derived: sum of 2 quarters · filed 2010-10-20 | $108.50M 10-Q · filed 2010-10-20 | $108.55M 10-Q · filed 2009-10-21 | $146.02M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-06-30 | $42.30M 10-Q · filed 2010-07-23 | $42.32M 10-Q · filed 2009-07-23 | $64.20M 10-Q · filed 2010-07-23 | $64.22M 10-Q · filed 2009-07-23 | $101.72M derived: sum of 3 quarters · filed 2011-02-01 | $133.75M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-03-31 | $21.90M 10-Q · filed 2010-04-20 | $59.42M derived: sum of 2 quarters · filed 2011-02-01 | $91.45M derived: sum of 3 quarters · filed 2011-02-01 | $124.17M derived: sum of 4 quarters · filed 2011-02-01 | ||||
| 2008-12-31 | $37.52M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $69.55M derived: sum of 2 quarters · filed 2011-02-01 | $102.27M derived: sum of 3 quarters · filed 2011-02-01 | $130.90M 10-K · filed 2011-02-01 | $130.89M 10-K · filed 2010-01-29 | |||
| 2008-09-30 | $32.03M 10-Q · filed 2009-10-21 | $64.75M derived: sum of 2 quarters · filed 2009-10-21 | $93.38M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $32.72M 10-Q · filed 2009-07-23 | $61.35M 10-Q · filed 2009-07-23 | ||||||
| 2007-12-31 | $92.70M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |